Cambridge, MA, United States of America

Ramsey Majzoub

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Intellia Therapeutics, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ramsey Majzoub. Retrieved from https://idiyas.com/inventor/ramsey-majzoub

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Ramsey Majzoub

Introduction

Ramsey Majzoub is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of novel lipid formulations for drug delivery.

Latest Patents

One of his key patents is titled "Modified Amine Lipids." This patent provides ionizable amine lipids and salts that are useful for delivering biologically active agents to cells. The disclosed ionizable amine lipids are particularly valuable in the formulation of lipid nanoparticle-based compositions, which are essential for preparing engineered cells.

Career Highlights

Ramsey Majzoub is currently associated with Intellia Therapeutics, Inc., a company focused on developing transformative medicines using CRISPR technology. His work at Intellia Therapeutics has positioned him at the forefront of innovative therapeutic solutions.

Collaborations

He collaborates with talented individuals such as Stephen S. Scully and Micah Maetani, contributing to a dynamic research environment that fosters innovation.

Conclusion

Ramsey Majzoub's work exemplifies the intersection of biotechnology and innovation, showcasing how his inventions can lead to advancements in medical treatments. His contributions continue to impact the field significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…